Frontiers in Pharmacology | Respiratory Pharmacology

Correction

Accepted on 30 May 2025

Correction: Uncovering the mechanism of resveratrol in the treatment of asthma: A network pharmacology approach with molecular docking and experimental validation

in Respiratory Pharmacology

Chunxiao Li
Xin Hou
Bowen Liu
Bingqing Sun
Mengqi Zhou
Shuwen Zhang
Jingyuan Zhang
Jiangtao Lin

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1637508

Original Research

Accepted on 30 May 2025

Oral Angiotensin-(1-7) formulation after established elastase-induced emphysema suppresses inflammation and restores lung architecture

in Respiratory Pharmacology

Giselle S Magalhaes
Alicia Villacampa
Maria Da Glória Rodrigues-Machado
Maria Jose Campagnole-Santos
Robson Augusto Souza Santos
Carlos F Sánchez-Ferrer
Concepción Peiró

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1540475

Original Research

Published on 30 May 2025

Efficacy and safety of a new drug formulation, amoxicillin-clavulanate-cineole, for adult lower respiratory tract infections: a nationwide observational study in Morocco

in Respiratory Pharmacology

Mohamed Chakib Benjelloun
Youness El Achhab
Chakib Nejjari
the ORCA Study Group

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1549014

310 views

Original Research

Published on 30 May 2025

D-cycloserine effects on COPD and depression in a murine experimental model

in Respiratory Pharmacology

Uriel Heresco-Levy
Jacob Haviv
Yehezkel G. Caine
Jimmy Bao
Tai-Yu Huang
Chien-Chang Shen
Naama R. Bogot

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1554337

152 views

Review

Published on 30 May 2025

Current advancements in the mechanisms and animal models of acute exacerbation of pulmonary fibrosis: a systematic review

in Respiratory Pharmacology

Kai Chen
Hailong Zhang
Zhaoxu Yao
Siyu Tao
Qian Ma

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1501085

194 views

Original Research

Accepted on 29 May 2025

Machine Learning-Based Prediction Model for Lung Ischemia-Reperfusion Injury: Insights from Disulfidptosis-Related Genes Author

in Respiratory Pharmacology

Yanpeng Zhang
Jingyang Sun
Yihan Lin
Rongxuan Jiang
Niuniu Dong
Huanhuan Dong
Peng Li
Jinteng Feng
Zijiang Zhu
Guangjian Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1545111

Editorial

Accepted on 26 May 2025

Editorial: Applications of AI, Machine Learning, Computational Medicine, and Bioinformatics in Respiratory Pharmacology

in Respiratory Pharmacology

Ashad Kabir
Paolo Montuschi
Kuang-Ming Liao
Mojtaba Amani

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1602941

482 views

Review

Accepted on 23 May 2025

Oxidative Stress in ARDS: Mechanisms and Therapeutic Potential

in Respiratory Pharmacology

Fengyun Wang
Ruiqi Ge
Yun Cai
Mingrui Zhao
Zhen Fang
Jingguo Li
Chengzhi Xie
Mei Wang
Wanyue Li
Xiaozhi Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1603287

111 views

Review

Published on 21 May 2025

Modulating mitochondria with natural extract compounds: from bench to clinical therapeutic opportunities for COPD

in Respiratory Pharmacology

Qiao Wang
Ziling Zeng
Linlin Guo
Kent E. Williams
Yun Zhang
Hongmei Tang
Hang Hu
Gang Qin
Kaijin Wang
Xing Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1531302

638 views

Original Research

Published on 20 May 2025

Longitudinal relationships between serum ferritin and prognosis among severe community-acquired pneumonia patients

in Respiratory Pharmacology

Jing Xu
Ming-Feng Han
Kai-Shu Ma
Ting Zhang
Rui-Rui Wang
Jing-Jing Zhang
Hui Zhao
Lin Fu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1556185

357 views

Original Research

Published on 16 May 2025

Uncovering the mechanism of resveratrol in the treatment of asthma: a network pharmacology approach with molecular docking and experimental validation

in Respiratory Pharmacology

Li Chunxiao
Hou Xin
Liu Bowen
Sun Bingqing
Zhou Mengqi
Zhang Shuwen
Zhang Jingyuan
Lin Jiangtao

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1596737

640 views

Original Research

Published on 14 May 2025

Roles of oral anticoagulant use on the risk of 28-day mortality and in-hospital mortality in patients with acute respiratory distress syndrome

in Respiratory Pharmacology

Jiayang Huang
Huijie An
Lin Cheng
Wangsheng Li
Ke Zhang
Dan Su

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1565312

429 views

Original Research

Accepted on 13 May 2025

Clinical features and genetic spectrum of children with primary ciliary dyskinesia in central China: A referral center retrospective analysis

in Respiratory Pharmacology

Xiaoning Zhang
Xiuhong Jin
Zhiying Zhang
Yanqiong Wang
Xiangfeng Zhang
Zhen Dong
Haiming Yang
Yuelin Shen

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1526675

128 views

Original Research

Published on 12 May 2025

Triglyceride-glucose index as an independent predictor of mortality in patients with chronic respiratory diseases

in Respiratory Pharmacology

Hongyu Lu
Jibo Li
Xinlong Liu
Pan Jiang
Yongwen Feng
Changshan Wang
Feng Xu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1474265

639 views

Original Research

Published on 08 May 2025

Prophylactic anticoagulant therapy is associated with improved survival in ICU patients with non-COVID-19 pneumonia: a retrospective cohort study

in Respiratory Pharmacology

Haiming Hu
Yixing Zhu
Ruikang Hu
Lijuan Zhao
Xiangwen Zeng
Xue Wu
Rui Qiu
Yihao Nie
Lokesh Sharma
De Chang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1597885

678 views

Original Research

Accepted on 06 May 2025

Real-World Treatment Persistence and Predictive Factors for Discontinuation of Antifibrotic Therapies in Patients with Idiopathic Pulmonary Fibrosis: A Post-Hoc Analysis of Two Multicenter Observational Cohort Studies in Poland

in Respiratory Pharmacology

Sebastian Majewski
Katarzyna Górska
Katarzyna B Lewandowska
Magdalena M Martusewicz-Boros
Małgorzata Sobiecka
Wojciech J Piotrowski

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1586197